FDA Raps Hospira for Repeat Violations at Kansas Plant

Drug Industry Daily
A A
The FDA slammed Hospira’s sterile drug facility in McPherson, Kansas, after finding the same violations during recent inspections that were flagged during earlier probes.

To View This Article:

Login

Subscribe To Drug Industry Daily